News
A proteogenomic study based on samples from two large population-based biobanks reveals multiple proteins genetically regulated by adiposity, as ...
UPPSALA, Sweden, September 19, 2023 (GLOBE NEWSWIRE) – Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink® Target ...
A team from Genentech leveraged samples from a clinical trial of the anti-IL6R drug tocilizumab in severe COVID-19 ...
Press Release: Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs
A group from Boston Children's Hospital used plasma proteomics to identify several IL-17 family cytokines as diagnostic markers ...
A study investigating the associations between circulating inflammatory proteins and neurological outcomes measured baseline proteomics in subjects who were followed ...
A large proteogenomics study into the genetic influences on inflammation-related proteins has provided important insights into the pathogenesis of ...
Leveraging Olink® panels to investigate samples from a phase I clinical trial for combined vaccine and viral latency-reversal therapy ...
UPPSALA, Sweden, August 8,2023 (GLOBE NEWSWIRE)